Ching-Yuan Li

Title: Ching-Yuan Li: Innovator in Pharmaceutical Compositions

Introduction

Ching-Yuan Li is a prominent inventor based in San Diego, CA, known for her significant contributions to the field of pharmaceutical compositions. With a total of 5 patents to her name, she has made strides in developing innovative treatments for various medical conditions.

Latest Patents

Her latest patents include compositions comprising PGI2-receptor agonists and processes for their preparation. These pharmaceutical compositions are designed to treat PGI2 related disorders, utilizing a specific compound known as 2-(((1r,4r)-4-(((4-chlorophenyl)(phenyl)carbamoyloxy)methyl)cyclohexyl)methoxy)acetic acid (Compound 1). Additionally, she has developed pharmaceutical compositions and dosage forms that include N-[5-(3,5-difluorobenzyl)-1H-indazol-3-yl]-4-(4-methyl-piperazin-1-yl)-2-(tetrahydro-2H-pyran-4-ylamino) benzamide, which are useful in treating cancer.

Career Highlights

Ching-Yuan Li has worked with notable companies such as Ignyta, Inc. and Arena Pharmaceuticals, Inc. Her work has focused on creating effective pharmaceutical solutions that address critical health issues.

Collaborations

Throughout her career, she has collaborated with professionals like Daniel Codallos, Jr. and Robert L. Orr, contributing to the advancement of her research and innovations.

Conclusion

Ching-Yuan Li's work in pharmaceutical compositions showcases her dedication to improving healthcare through innovative inventions. Her contributions continue to impact the field positively.